CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC … – GlobeNewswire (press release)
|
CRISPR Therapeutics Highlights New Additions to Portfolio of Allogeneic CRISPR-based CAR-T Therapies at SITC …
GlobeNewswire (press release) ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a genome editing company focused on creating transformative medicines for serious diseases, today described advances in its … CRISPR Therapeutics Earnings Update: Maintains The Lead In Cas9 Clinical Trials Head to Head Comparison: Crispr Theraptc (CRSP) and Editas Medicine (EDIT) CRISPR THERAPTC (CRSP) Announces Earnings Results |
